Andrew Biggin

Associate Professor Andrew Biggin is a Specialist Paediatric Endocrinologist at the Children's Hospital at Westmead and Associate Professor at the University of Sydney's Children's Hospital Westmead Clinical School. He holds qualifications including a PhD in neuromuscular junction plasticity (University of London), MBBS, and FRACP. His research focuses on bone dysplasias, metabolic bone disease, osteoporosis, and innovative IT applications in clinical care.

• Education: PhD (University of London), MBBS, FRACP.
• Affiliations: Royal Australasian College of Physicians (RACP), Australian Paediatric Endocrine Group (APEG), and others.

Current research projects include whole genome sequencing for skeletal genetic disorders, KRN23 efficacy in X-linked Hypophosphatemia, and beta-cell preservation in Type 1 Diabetes. His work emphasizes translational research, such as CRISPR/Cas9 studies on genetic variants.

Publications span topics like bisphosphonates in Osteogenesis Imperfecta, burosumab therapy for XLH, and pediatric bone health guidelines. Awards include the 2017 Vice-Chancellor’s Award for Research Supervision.

• Grants/Advising: Supervised multiple HDR students and contributed to clinical trials (e.g., burosumab phase 3 trials).
• Labs/Teams: Collaborates with Dr. Lucinda Lee on functional genomics and CRISPR-based research.